We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

CRF Health Launches TrialConsent, a TrialMax Platform Extension

Product News   May 17, 2016

 
CRF Health Launches TrialConsent, a TrialMax Platform Extension
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Byondis’ Investigational Antibody-Drug Conjugate Selected for Trial in Early-Stage Breast Cancer

Product News

Byondis has announced that Quantum Leap selected the company’s investigational antibody-drug conjugate SYD985 for a new investigational treatment arm in its ongoing I-SPY 2 TRIAL™ for neoadjuvant treatment of locally advanced breast cancer.

READ MORE

Freyr Launches COVID-19 Web Platform with Regulatory Information for Manufacturers

Product News

Freyr has announced the launch of a web platform for COVID-19 driven with real-time information for manufacturers to help them get to market and support them in emergency use authorizations with global regulatory authorities.

READ MORE

My Personal Therapeutics and Pentavere Receive EUREKA Funding to Support AI-based Personalized Cancer Treatment Plans

Product News

My Personal Therapeutics and Pentavere have announced their successful EUREKA Collaborative R&D: AI and Quantum Technologies Competition award for project titled "Utilisation of AI to develop Personalised Treatment Plans for cancer".

READ MORE

Like what you just read? You can find similar content on the communities below.

Informatics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE